Allied Market Research


Naftifine Hydrochloride Ointment Market

Naftifine Hydrochloride Ointment Market Size, Share, Competitive Landscape and Trend Analysis Report by Patient Group (Adults, Children) and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce): Global Opportunity Analysis and Industry Forecast, 2023-2032

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Naftifine hydrochloride (naftifine), chemically known as (E)-N-Cinnamyl-N-methyl-1-napthalenemethylamine hydrochloride is an antifungal drug used to topically treat fungal infections such as tinea pedis (athletes foot), tinea cruris (jock itch), tinea corporis (ringworm), and others. It is a synthetic allylamine antifungal compound. Naftifine is only prescribed for topical application. This ointment has a complete anti-microbial mechanism of action comprising anti-fungal, anti-bacterial, and anti-inflammatory activity.

Rise in awareness boosts the growth of the market. Furthermore, increase in prevalence rate of fungal infections and rise in disposable income of population are key factors that propel the naftifine hydrochloride ointment market. However, minor side effects associated with this drug and stringent government regulations toward naftifine hydrochloride impede the growth of this market to a certain extent.

The global methadone market is segmented on the basis of patient group, distribution channel and geography. Based on patient group, the market is bifurcated into adults and children. On the distribution channel, this market is segmented into hospital pharmacy, retail pharmacy, and ecommerce. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as Merz Dermatology, Parchem Fine & Specialty Chemicals, LGM Pharma, Sebela Pharmaceuticals, Inc., Erregierre S.P.A., Simagchem Corporation, Taro Pharmaceutical Industrues, Ltd., Renaissance Pharma, Inc., Shanghai Yisa Biotechnology Co., Ltd. and Shaanxi TOP Pharm Chemical Co., Ltd. provided in this report.

Key Benefits:

  • The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
  • Extensive analysis by product elucidates the use of naftifine hydrochloride in medical settings.

Naftifine Hydrochloride Ointment Market Report Highlights

Aspects Details
Naftifine Hydrochloride Ointment Market By Patient Group
By Patient Group
  • Adults
  • Children
Naftifine Hydrochloride Ointment Market By Distribution Channel
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • E-Commerce
Naftifine Hydrochloride Ointment Market By Region
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players
Key Market Players

Sebela Pharmaceuticals Inc., Merz Dermatology, Parchem Fine & Specialty Chemicals, LGM Pharma, Taro Pharmaceutical Industrues, Ltd., Erregierre S.P.A., Shaanxi TOP Pharm Chemical Co., Ltd., Shanghai Yisa Biotechnology Co., Ltd., Simagchem Corporation, Renaissance Pharma, Inc.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Naftifine Hydrochloride Ointment Market

Global Opportunity Analysis and Industry Forecast, 2023-2032